Elbion Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $18M
Latest Deal Amount

Elbion General Information

Description

Provider of pharmaceutical research and development services. The company operates as a specialty pharmaceutical company focused on the development and commercialization of therapeutics for neurological diseases and immunological disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • Meissner Straße 191
  • 01445 Radebeul
  • Germany
+49 0351 00000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Elbion Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 14-Nov-2008 $18M 000.00 0000 Completed Generating Revenue
1. Early Stage VC (Series A) 10-Jul-2005 000.00 000.00 Completed Generating Revenue
To view Elbion’s complete valuation and funding history, request access »

Elbion Patents

Elbion Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2706986-A1 Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10 Abandoned 30-Nov-2007 0000000000
AU-2008329072-A1 Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10 Abandoned 30-Nov-2007 0000000000
US-20090143391-A1 Aryl and heteroaryl fused imidazo [1,5-a] pyrazines as inhibitors of phosphodiesterase 10 Abandoned 30-Nov-2007 0000000000 0
US-20090143392-A1 Methods of treating obesity and metabolic disorders Abandoned 30-Nov-2007 00000000000 0
EP-2227472-A1 Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10 Withdrawn 30-Nov-2007 C07D487/04
To view Elbion’s complete patent history, request access »

Elbion Executive Team (1)

Name Title Board Seat Contact Info
Bernd Kastler Chief Executive Officer
To view Elbion’s complete executive team members history, request access »

Elbion Board Members (1)

Name Representing Role Since
Luc Philips Self Chairman 000 0000
To view Elbion’s complete board members history, request access »

Elbion Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
3i Group PE/Buyout Minority 000 0000 000000 0
BayTech Venture Capital Venture Capital Minority 000 0000 000000 0
Burrill & Co Merchant Banking Firm Minority 000 0000 000000 0
Deutsche Venture Capital Corporate Venture Capital Minority 000 0000 000000 0
Idinvest Partners PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Elbion Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 000 19-Jan-2007 000000000 Buildings and Property 00000 000
4 AZA Bioscience 12-Aug-2006 Merger/Acquisition Biotechnology
To view Elbion’s complete investments and acquisitions history, request access »